Can Singapore learn from the European Health Data Space Act (“EHDSA”)? A discussion on the NEHR and the Proposed Health Information Bill (“SG HIB”)
Introduction The National Electronic Health Record (“NEHR”) system was set up with the goal of serving as a repository to collect different types of data of the patients’ summary health conditions and records based on their encounters with healthcare professions and clinicians throughout their life.
Mergers and Acquisitions – David Getting Ready for the Takeover
Following our first article “Goliath taking over David”[1], we will now look at ways in which David should get itself ready for such a transaction.
Mergers and Acquisitions – As Goliath takes over David – are the risks worth it?
Today’s mergers and acquisitions landscape involves more transactions between companies of difference in sizes (in terms of assets,
Taking the driving seat on pharma and life science investments
Investments in the life science and pharmaceutical industries are a different ballgame.
A Practical Checklist of Things to Avoid with New Launches of Prescription-Only Medicines in Singapore
Pharmaceutical companies that plan launches of prescription-only medicines need to be aware: there are regulatory matters in Singapore things which can interrupt your launch if they’re not sufficiently attended to.
“Earned Media” – Legitimate Publicity for Medical Products or Disguised Product Promotion?
It should come as no surprise that the marketing of pharmaceutical products is regulated – and that even advertisements of such products are regulated.
The Thaler decision – AI Need Not Apply … At least Not yet….
The UK Supreme Court held, on 20 December 2023, that an AI system could NOT be an inventor for two UK Patent applications.
Black Cats & Generative A.I. – How LLMs are looked at from a Copyright perspective
Developers and users of Generative A.I. (“Gen A.I.”) can find themselves having to navigate copyright challenges but to do so requires some understanding of both how a Gen A.I. model manipulates copyright works as part of its training and development and how copyright law might apply to such use.
A.I. & Copyright – Did Singapore’s Copyright Act 2021 solve copyright problems in the Training of A.I.?
When Artificial Intelligence models are trained against data, the potential for copyright infringement exists under the laws of some, if not most, countries. Did Singapore’s Copyright Act 2021 solve this problem? This article explores what Singapore’s changes to its laws mean. By Jeffrey Lim